Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population

Cancer Research

Volumn 61, Issue 15, 2001, Pages 5869-5874

  Giguère, Yves ^a   Forest, Veronique Isabelle ^a   Dodin, Sylvie ^a   Rousseau, Francois ^a   Dewailly, Eric ^b   Ayotte, Pierre ^b   Demers, Alain ^b   Brisson, Jacques ^b   Laflamme, Nathalie ^c  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Signalgene Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; POLYGLUTAMINE;

ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PEPTIDES; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN;

EID: 0035421325     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer
2. Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland
3. Breast cancer hypothesis: A single cause for the majority of cases
4. Etiologic factors of breast cancer elucidated by a study of unselected twins
5. Inheritance of human breast cancer: Evidence for autosomal dominant transmission in high-risk families
6. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
7. BRCA1 mutations in primary breast and ovarian carcinomas
8. Identification of the breast cancer susceptibility gene BRCA2
9. The complete BRCA2 gene anal mutations in chromosome 13q-linked kindreds
10. Population genetics of BRCA1 and BRCA2
11. A systematic review of genetic polymorphisms and breast cancer risk
12. Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population
13. Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty
14. Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility
15. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
16. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk
17. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
18. Androgen receptor CAG repeat lengths in prostate cancer: Correlation with age of onset
19. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: Possible pathogenetic relevance for the (CAG)n-expanded neuronopathies
20. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function
21. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
22. The role of androgen receptor gene mutations in male breast carcinoma
23. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat
24. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years
25. The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer
26. The CAG repeat within the androgen receptor gene in male breast cancer patients
27. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations
28. High throughput and economical mutation detection and RFLP analysis using a mini-method for DNA preparation from whole blood and acrylamide gel electrophoresis
29. Characterization and expression of a cDNA encoding the human androgen receptor
30. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer
31. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population
32. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia
33. Androgen receptor gene polymorphism and prostate zonal volumes in Australian and Chinese men
34. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men
35. Long polyglutamine tracts in the androgen receptor are associated with reduced transactivation, impaired sperm production, and male infertility
36. Isolation and characterization of ARA 160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells
37. Inhibition of p 160-mediated coactivation with increasing androgen receptor polyglutamine length
38. Polyglutamine-expanded androgen receptors from aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone
39. Dihydrotestosterone affects the growth of hormone-unresponsive breast cancer cells: An indirect action
40. Indirect growth inhibition of the MDA-MB-231 hormone-independent breast cancer cell line by dihydrotestosterone
41. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor
42. Adrenal androgens and human breast cancer: A new appraisal
43. Urinary androgens and breast cancer risk: Results from a long-term prospective study based in Guernsey
44. Prostate cancer and the androgen receptor